Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $65,660.15 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) Director Blake Borgeson sold 8,885 shares of the company’s stock in a transaction dated Tuesday, June 27th. The shares were sold at an average price of $7.39, for a total transaction of $65,660.15. Following the transaction, the director now directly owns 7,528,989 shares of the company’s stock, valued […]

Related Keywords

Blake Borgeson ,Recursion Pharmaceuticals Inc ,Recursion Pharmaceuticals Stock ,Securities Exchange Commission ,Nasdaq ,News Ratings For Recursion Pharmaceuticals Daily ,Recursion Pharmaceuticals Company Profile ,Principal Financial Group Inc ,Quarter For Recursion Pharmaceuticals ,Recursion Pharmaceuticals ,Mitsubishi Ufj ,Morgan Stanley ,Hedge Funds Weigh In On Recursion Pharmaceuticals ,Needham Company ,Manufacturers Life Insurance Company ,Kokusai Asset Management Co ,Vident Investment Advisory ,Free Report ,Director Blake Borgeson ,Exchange Commission ,Financial Group ,Investment Advisory ,Asset Management ,Recursion Pharmaceuticals Daily ,